Description
Antibody to CEACAM is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEACAM positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.CEACAM is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors.
Bioinformatics
| Uniprot |
|
| Product By Gene ID |
634 |
